当前位置:首页 - 行情中心 - 康泰生物(300601) - 财务分析 - 资产负债表

康泰生物

(300601)

  

流通市值:168.46亿  总市值:208.98亿
流通股本:9.00亿   总股本:11.17亿

资产负债表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
流动资产:
  货币资金216,201,021.06219,937,690.38432,840,378.47190,632,300.7
  交易性金融资产30,058,300-0120,080,100
  应收票据及应收账款2,913,497,715.052,863,081,707.322,787,045,936.422,878,860,051.21
  其中:应收票据-8,817,001.01-49,545
        应收账款2,913,497,715.052,854,264,706.312,787,045,936.422,878,810,506.21
  应收款项融资--00
  预付款项17,238,756.2124,177,808.4726,578,453.9329,731,844.17
  其他应收款合计9,665,759.088,580,322.3510,536,156.678,719,019.78
  存货679,581,268.84726,163,704.93782,767,957.21868,334,750.87
  其他流动资产2,224,776,127.332,387,591,3122,202,520,055.691,754,266,199.01
  流动资产合计6,091,018,947.576,229,532,545.456,242,288,938.395,850,624,265.74
非流动资产:
  其他权益工具投资1-0-
  投资性房地产773,040,611.91783,356,053.57787,547,166.28489,733,719.06
  固定资产4,132,994,765.564,193,402,763.114,235,306,504.994,321,958,518.78
  在建工程959,925,440.54962,817,334.98990,283,518.031,311,496,175.49
  无形资产415,053,694.91427,583,964.18436,663,032.83445,751,601.51
  开发支出134,453,102.09115,849,555.4597,794,434.5381,086,019.24
  长期待摊费用148,011,021.76159,226,115.56170,461,150.9175,555,755.03
  递延所得税资产732,933,317.78693,042,229.68697,626,350.41643,572,146.18
  其他非流动资产741,493,899.77690,117,086.56905,743,398.961,295,761,513.46
  非流动资产合计8,037,905,855.328,025,395,103.098,321,425,556.948,664,915,448.75
  资产总计14,128,924,802.8914,254,927,648.5414,563,714,495.3314,515,539,714.49
流动负债:
  短期借款39,900,00035,606,312.534,102,910.54155,678,905.79
  应付票据及应付账款704,585,457.7709,837,080.52847,825,622.04789,032,555.1
  其中:应付票据142,496,467.9152,362,517.69186,780,333.79162,189,348.62
        应付账款562,088,989.8557,474,562.83661,045,288.25626,843,206.48
  预收款项3,257,617.78733,285.43858,863.082,180,627.74
  合同负债18,159,321.9319,347,470.2618,421,267.8621,646,679.08
  应付职工薪酬31,542,317.4839,662,035.1858,882,396.132,619,203.3
  应交税费18,297,706.4114,580,910.122,289,407.6317,692,827.13
  其他应付款合计1,442,636,970.871,395,966,0851,461,258,486.91,488,856,324.15
  一年内到期的非流动负债28,173,926.67111,168,017.6202,954,572.59110,446,791.18
  其他流动负债530,369.37585,017.04552,638.05618,702.36
  流动负债合计2,287,083,688.212,327,486,213.632,647,146,164.792,618,772,615.83
非流动负债:
  长期借款--085,000,000
  应付债券1,828,502,013.31,807,229,504.051,786,479,371.341,765,533,392.42
  预计负债143,120,378.89151,281,291.43186,717,135.9130,151,967.72
  递延收益240,094,075.8251,052,687.98247,824,792.28281,656,436.93
  递延所得税负债31,201,827.6434,483,765.2234,521,68224,937,092.21
  非流动负债合计2,242,918,295.632,244,047,248.682,255,542,981.532,187,278,889.28
  负债合计4,530,001,983.844,571,533,462.314,902,689,146.324,806,051,505.11
所有者权益(或股东权益):
  实收资本(或股本)1,116,928,5371,116,927,8871,116,927,7371,116,916,739
  其他权益工具511,042,017.06511,044,650.24511,045,417.19511,101,148.51
  资本公积5,511,644,315.265,510,766,852.125,510,725,626.715,409,668,507.43
  其他综合收益-186,905.8-147,820.98-90,939.67-137,744.56
  盈余公积347,128,374.64347,128,374.64347,128,374.64327,558,677.67
  未分配利润2,112,396,887.742,197,821,795.312,175,387,706.752,344,400,715.39
  归属于母公司股东权益合计9,598,953,225.99,683,541,738.339,661,123,922.629,709,508,043.44
  少数股东权益-30,406.85-147,552.1-98,573.61-19,834.06
  股东权益合计9,598,922,819.059,683,394,186.239,661,025,349.019,709,488,209.38
  负债和股东权益合计14,128,924,802.8914,254,927,648.5414,563,714,495.3314,515,539,714.49
公告日期2025-08-222025-04-212025-04-212024-10-26
审计意见(境内)标准无保留意见
TOP↑